NFL Biosciences (STU:82F) ROCE % : -318.12% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. NFL Biosciences's annualized ROCE % for the quarter that ended in Dec. 2023 was -318.12%.

NFL Biosciences ROCE % Historical Data

The historical data trend for NFL Biosciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences ROCE % Chart

NFL Biosciences Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-141.92

-111.39

-65.11

-138.51

-687.60

NFL Biosciences Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial			-	-93.36	-199.30	-336.02	-318.12

NFL Biosciences ROCE % Calculation

NFL Biosciences's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-4.105	/	( ( (2.395 - 1.551)	+	(3.971 - 3.621) )	/ 2 )
	=	-4.105	/	( (0.844	+	0.35)	/ 2 )
	=	-4.105	/	0.597
	=	-687.60 %

NFL Biosciences's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-3.59	/	( ( (5.578 - 3.671)	+	(3.971 - 3.621) )	/ 2 )
	=	-3.59	/	( ( 1.907	+	0.35 )	/ 2 )
	=	-3.59	/	1.1285
	=	-318.12 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

NFL Biosciences (STU:82F) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

NFL Biosciences ROCE % Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

NFL Biosciences (STU:82F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (STU:82F) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

ALNFL:France 82F:Germany

Address

199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170

Website

https://www.nflbiosciences.com/

NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences (STU:82F) Headlines

No Headlines